Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock
SAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. SAN has a medium profitability rating, but doesn't score so well on its financial health evaluation. SAN is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROIC | 13.4% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.49 | ||
| Fwd PE | 9.38 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 4 / 10 to SAN.PA.
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
SANOFI (SAN.PA) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 10.49 and the Price/Book (PB) ratio is 2.64.
The financial health rating of SANOFI (SAN.PA) is 3 / 10.